Organon to Move to Truzo, Becomes 3rd Drugmaker to Use Kalderos’ Platform for 340B Contract Pharmacy Restrictions
The New Jersey-based spin-off of pharmaceutical giant Merck announced Wednesday that it will become the third drugmaker to utilize a [...]

